pppApG
Product Specifications
UNSPSC Description
pppApG is a starting product of both vRNA (viral RNA) and cRNA (complementary RNA) synthesis. pppApG can be used for influenza virus research[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/pppapg.html
Solubility
10 mM in DMSO
Smiles
O[C@H]([C@@H]1O[P](OC[C@H]([C@H]2O)O[C@](N3C(NC(N)=NC4=O)=C4N=C3)([H])[C@@H]2O)(O)=O)[C@](O[C@@H]1CO[P](O[P](O[P](O)(O)=O)(O)=O)(O)=O)([H])N5C6=NC=NC(N)=C6N=C5
Molecular Weight
852.39
References & Citations
[1]Te Velthuis AJ, et al. Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol. 2016 Aug;14(8):479-93.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-137660/pppApG-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-137660/
Clinical Information
No Development Reported
CAS Number
68892-47-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1108372-01 0.02 mg (E-Coli)
Recombinant Burkholderia pseudomallei PKHD-type hydroxylase BURPS1106A_A1609 (BURPS1106A_A1609)
Ask
View Details 
MBS1108372-02 0.1 mg (E-Coli)
Recombinant Burkholderia pseudomallei PKHD-type hydroxylase BURPS1106A_A1609 (BURPS1106A_A1609)
Ask
View Details MBS1108372-03 0.02 mg (Yeast)
Recombinant Burkholderia pseudomallei PKHD-type hydroxylase BURPS1106A_A1609 (BURPS1106A_A1609)
Ask
View Details MBS1108372-04 0.1 mg (Yeast)
Recombinant Burkholderia pseudomallei PKHD-type hydroxylase BURPS1106A_A1609 (BURPS1106A_A1609)
Ask
View Details MBS1108372-05 0.02 mg (Baculovirus)
Recombinant Burkholderia pseudomallei PKHD-type hydroxylase BURPS1106A_A1609 (BURPS1106A_A1609)
Ask
View Details MBS1108372-06 0.02 mg (Mammalian-Cell)
Recombinant Burkholderia pseudomallei PKHD-type hydroxylase BURPS1106A_A1609 (BURPS1106A_A1609)
Ask
View Details